Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up
Conclusion
During the first year of the pandemic, there was a decrease in aSAH admissions volume, driven by a decrease in mild to moderate presentation of aSAH. There was an increase in the ruptured aneurysm coiling rate but neither change in the ruptured aneurysm clipping rate nor change in aSAH in-hospital mortality.
Trial registration number
NCT04934020.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: SVIN COVID-19 Global SAH Registry, Nguyen, Qureshi, Klein, Yamagami, Mikulik, Etminan, Abdalkader, Mansour, Czlonkowska, Lo, Sathya, Demeestere, Tsivgoulis, Sakai, Sedova, Kristoffersen, Mohammaden, Lereis, Scollo, Ma, Rahman, Bonnet, Cortier, Raedt, Lemm Tags: Editor's choice, COVID-19 Cerebrovascular disease Source Type: research
More News: Brain | COVID-19 | Databases & Libraries | Hemorrhagic Stroke | Neurology | Neurosurgery | Pandemics | Psychiatry | Stroke | Study | Subarachnoid Hemorrhage